DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for durlobactam sodium; durlobactam sodium; sulbactam sodium and what is the scope of freedom to operate?
Durlobactam sodium; durlobactam sodium; sulbactam sodium
is the generic ingredient in one branded drug marketed by Entasis Therap and is included in one NDA. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.Durlobactam sodium; durlobactam sodium; sulbactam sodium has seventy-eight patent family members in forty-two countries.
One supplier is listed for this compound.
Summary for DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
| International Patents: | 78 |
| US Patents: | 4 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| DailyMed Link: | DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
Generic Entry Date for DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM*:
Constraining patent/regulatory exclusivity:
GENERATING ANTIBIOTIC INCENTIVES NOW Dosage:
POWDER;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Anatomical Therapeutic Chemical (ATC) Classes for DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
US Patents and Regulatory Information for DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Entasis Therap | XACDURO (COPACKAGED) | durlobactam sodium; durlobactam sodium; sulbactam sodium | POWDER;INTRAVENOUS | 216974-001 | May 23, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Entasis Therap | XACDURO (COPACKAGED) | durlobactam sodium; durlobactam sodium; sulbactam sodium | POWDER;INTRAVENOUS | 216974-001 | May 23, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Entasis Therap | XACDURO (COPACKAGED) | durlobactam sodium; durlobactam sodium; sulbactam sodium | POWDER;INTRAVENOUS | 216974-001 | May 23, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Entasis Therap | XACDURO (COPACKAGED) | durlobactam sodium; durlobactam sodium; sulbactam sodium | POWDER;INTRAVENOUS | 216974-001 | May 23, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for DURLOBACTAM SODIUM; DURLOBACTAM SODIUM; SULBACTAM SODIUM
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Singapore | 11201405965R | HETEROBICYCLIC COMPOUNDS AS BETA-LACTAMASE INHIBITORS | ⤷ Sign Up |
| Taiwan | I597281 | ⤷ Sign Up | |
| Philippines | 12014502224 | HETEROBICYCLIC COMPOUNDS AS BETA-LACTAMASE INHIBITORS | ⤷ Sign Up |
| Eurasian Patent Organization | 033829 | КОМБИНИРОВАННАЯ ТЕРАПИЯ ДЛЯ ЛЕЧЕНИЯ УСТОЙЧИВЫХ БАКТЕРИАЛЬНЫХ ИНФЕКЦИЙ (COMBINATION THERAPY FOR TREATMENT OF RESISTANT BACTERIAL INFECTIONS) | ⤷ Sign Up |
| >Country | >Patent Number | >Title | >Estimated Expiration |
